Observations placeholder
Xifaxan
Identifier
020386
Type of Spiritual Experience
Number of hallucinations: 5
Background
A description of the experience
Rifaximin (trade names:RCIFAX, Rifagut, Xifaxan, Zaxine) is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, for which it received orphan drug status from the U.S. Food and Drug Administration in 1998.
On Dec, 30, 2016 2,094 people reported to have side effects when taking Xifaxan.
Among them, 5 people (0.24%) have Hallucination
On Feb, 16, 2016: 600 people reported to have side effects when taking Xifaxan. Among them, 20 people (3.33%) have Death.
Time on Xifaxan when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Xifaxan :
| Female | Male | |
| Death | 77.78% | 22.22% |
Age of people who have Death when taking Xifaxan :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.88% | 23.53% | 70.59% |